Promisia Integrative launches high risk rights issue

Promisia Integrative launches high risk rights issue
Jenny Ruth
By Jenny Ruth Dec. 5 (BusinessDesk) - Dietary supplements company Promisia Integrative is warning investors that if they participate in its $1.67 million capital raising they run a high risk of losing their money. The company has been operating with the financial support of its largest shareholder, director Tom Brankin’s family trust, and now owes him $1.6 million since MedSafe issued a warning in February that its Arthrem supplement intended to promote joint health may cause liver damage. That warning was repeated last month when MedS...